NCCS Cancer Policy Roundtable

In 2014, NCCS will launch its 14th year of semi-annual Cancer Policy Roundtable “think tank” meetings, convening stakeholders in the cancer community to discuss pressing issues related to cancer research, development of new cancer therapies, and the delivery of quality cancer care. Participants will include advocates, providers, payers, researchers, government officials, and pharmaceutical and biotechnology company representatives. The 2014 meetings will be held in Washington, D.C. on April 9-10, 2014 and in November 5-6, 2014

The faculty that present at the Cancer Policy Roundtable range from public and health policy experts to representatives from the National Institutes of Health, Food and Drug Administration, Centers for Medicare and Medicaid Services, Congressional Health Policy Advisors and leaders in health insurance, pharmaceutical, and biotechnology industries.

These meetings are a great opportunity for interested parties to come together and discuss timely and compelling issues.  Specific objectives and outcomes are unique to each meeting, however past meetings have focused on topics such as clinical trials, expanded access programs, Medicare reimbursement, healthcare reform and other relevant topics.

For information on how to become a participant of this event, please contact us.

Private Page Access: 2014 CPR Materials

Click Here

Sponsors and Memberships

AdvaMed
Amgen
Bayer HealthCare LLC
BIO
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Daiichi Sankyo
Eisai
Emergent BioSolutions
Genentech
GlaxoSmithKline
Lilly Oncology
Merck
Millennium:The Takeda Oncology Company
Novartis Oncology
Onyx
Pfizer
PhRMA
Teva Oncology
Wellpoint Foundation
(as of 4/3/2014)